← Eichor
Condition: Toxicity Drug Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Toxicity Drug

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NA · 1 location(s) · Dena h. Al-Tameemi · NCT07273812Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06664528Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NA · 2 location(s) · Jessa Hospital · NCT04979078Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer:
Phase N/A · 1 location(s) · Fundación Pública Andaluza para la Investigación Biomédica A · NCT07582887Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06549621Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Phase 2 · 10 location(s) · Rutgers, The State University of New Jersey · NCT05559164Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic E
EARLY_Phase 1 · 1 location(s) · Peng Zhang · NCT06119490A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy
EARLY_Phase 1 · 1 location(s) · University of Rochester · NCT05530655Long Term Outcomes After Vestibular Implantation
NA · 1 location(s) · Johns Hopkins University · NCT06500975Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening
Phase N/A · 5 location(s) · Region Jönköping County · NCT07273357Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
Phase N/A · 2 location(s) · Universitair Ziekenhuis Brussel · NCT06387901Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning
NA · 1 location(s) · Sherief Abd-Elsalam · NCT04499885Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169Immune Tolerance Induction After Liver Transplantation
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT07269041LYell SYndrome MEsenchymal Stromal Cells Treatment
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04711200TDM for Optimized Outcome in Patients With mRCC.
Phase N/A · 1 location(s) · Niels Fristrup · NCT04659343Assessment of Methadone Dose Taken
Phase N/A · 1 location(s) · Cari Health Inc. · NCT05981573Atrial Fibrillation in Active Cancer Patients
Phase N/A · 1 location(s) · University Hospital, Caen · NCT04696081Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Combined Gastrointestinal Decontamination in Acute Severe Poisoning
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07201311Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in
NA · 1 location(s) · Azienda Sanitaria Locale di Asti · NCT07524829Ofloxacin Concentration-toxicity Relationship in the Elderly
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT04496024Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT05840575Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis
Phase 4 · 1 location(s) · Mahidol University · NCT06484530Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botani
NA · 1 location(s) · University of Miami · NCT04650256Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Phase 2 · 9 location(s) · Matrix Biomed, Inc. · NCT03480971Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
NA · 1 location(s) · Erasmus Medical Center · NCT05652673Development of an Aptamer-based Lateral Flow Device for Point-of-care Detection of Toxic Chinese Medicine Herbs (ALPTH P
Phase N/A · 2 location(s) · The University of Hong Kong · NCT07456592
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.